Pharma Eases onto the Grid, but Desktop Deals Highlight Remaining Obstacles | GenomeWeb

NEW YORK, Sept. 13 - Pharma isn't known for its "power to the people" philosophy, but when it comes to computational power, pharmaceutical companies are embracing the idea.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.